Last $50.04 USD
Change Today +0.43 / 0.87%
Volume 4.4M
TEVA On Other Exchanges
Symbol
Exchange
New York
Tel Aviv
OTC US
Mexico
Frankfurt
As of 3:11 PM 04/16/14 All times are local (Market data is delayed by at least 15 minutes).

teva pharmaceutical-sp adr (TEVA) Snapshot

Open
$50.04
Previous Close
$49.61
Day High
$50.52
Day Low
$50.02
52 Week High
04/2/14 - $54.70
52 Week Low
11/5/13 - $36.26
Market Cap
42.4B
Average Volume 10 Days
7.9M
EPS TTM
--
Shares Outstanding
848.0M
EX-Date
02/20/14
P/E TM
--
Dividend
$1.38
Dividend Yield
2.61%
Current Stock Chart for TEVA PHARMACEUTICAL-SP ADR (TEVA)

teva pharmaceutical-sp adr (TEVA) Details

Teva Pharmaceutical Industries Limited, together with its subsidiaries, develops, manufactures, sells, and distributes pharmaceutical products worldwide. The company offers generic pharmaceutical products; and basic chemicals, as well as specialized product families. Its products include Copaxone for multiple sclerosis; Azilect for the treatment of Parkinson’s disease; Provigil and Nuvigil to treat excessive sleepiness associated with narcolepsy, obstructive sleep apnea, and shift work disorders; Fentora and Actiq to treat pain in opioid-tolerant adult patients with cancer; and Amrix for muscle spasm in acute, painful, and musculoskeletal conditions. The company also offers Treanda to treat chronic lymphocytic leukemia and indolent B-cell non-Hodgkin’s lymphoma; Tevagrastim that stimulate the production of white blood cells; Lonquex, which reduces the duration of neutropenia and incidence of febrile neutropenia in adult patients; Eporatio that stimulates the production of red blood cells; and Synribo for chronic myeloid leukemia. In addition, it provides ProAir for the treatment of bronchospasm; QVAR for the treatment of asthma; Qnasl Nasal Aerosol for nasal allergy symptoms in adults; Plan B One-Step and Quartette, which prevents pregnancy; Seasonique and LoSeasonique that are extended-cycle oral contraceptives; Zoely, a regimen combination contraceptive oral pill; and ParaGard, a non-hormonal intrauterine contraceptive. Further, the company offers Enjuvia for vasomotor symptoms associated with menopause; hormone therapy treatments for menopause/perimenopause; therapies for infertility and urinary incontinence; and manufactures active pharmaceutical ingredients. It also distributes third party products. Teva Pharmaceutical Industries Limited was founded in 1901 and is headquartered in Petach Tikva, Israel.

44,945 Employees
Last Reported Date: 02/10/14
Founded in 1901

teva pharmaceutical-sp adr (TEVA) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

teva pharmaceutical-sp adr (TEVA) Key Developments

Teva Pharmaceutical Industries Ltd. Announces Launch of Generic Lunesta(R) Tablets in United States

Teva Pharmaceutical Industries Ltd. announced the launch of the generic equivalent to Lunesta(R) (Eszopiclone Tablets, CIV), 1, 2 and 3 mg, in the United States. Lunesta(R) Tablets, marketed by Sunovion Pharmaceuticals, had annual sales of approximately $852 million in the United States.

Teva Announces First Approval and Launch of Generic Lovaza(R) Capsules in United States

Teva Pharmaceutical Industries Ltd. announced the approval of the generic equivalent to Lovaza(R) (Omega-3-Acid Ethyl Esters Capsules, USP), in the United States. Teva believes it is first-to-file and thus far is the only Company to receive an approval from FDA. Teva plans to commence shipping immediately. Lovaza(R) Capsules, marketed by GlaxoSmithKline, had annual sales of approximately $1.1 billion in the United States.

Teva Pharmaceutical Industries Limited Presents at Boston Biotech BD Boston Conference, Mar-25-2014 12:50 PM

Teva Pharmaceutical Industries Limited Presents at Boston Biotech BD Boston Conference, Mar-25-2014 12:50 PM. Venue: Four Seasons Hotel, 200 Boylston Street, Boston, MA 02116, United States. Speakers: Ivana Magovcevic-Liebisch, Head of Corporate Business Development and Senior Vice President.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
TEVA:US $50.05 USD +0.435

TEVA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott Laboratories $38.15 USD +0.18
AbbVie Inc $47.98 USD +0.12
Baxter International Inc $73.21 USD -0.15
Eli Lilly & Co $59.83 USD +0.41
Johnson Matthey PLC 3,118 GBp +38.00
View Industry Companies
 

Industry Analysis

TEVA

Industry Average

Valuation TEVA Industry Range
Price/Earnings 33.2x
Price/Sales 2.1x
Price/Book 1.9x
Price/Cash Flow 37.1x
TEV/Sales 1.7x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TEVA PHARMACEUTICAL-SP ADR, please visit www.tevapharm.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.